Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study Journal Article


Authors: Long, T. E.; Indridason, O. S.; Palsson, R.; Rognvaldsson, S.; Love, T. J.; Thorsteinsdottir, S.; Sverrisdottir, I. S.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B. A.; Sigurdardottir, M.; Thorsteinsdottir, I.; Olafsson, I.; Thordardottir, A. R.; Eythorsson, E.; Jonsson, A.; Gislason, G.; Olafsson, A.; Steingrimsdottir, H.; Hultcrantz, M.; Durie, B. G. M.; Harding, S.; Landgren, O.; Kristinsson, S. Y.
Article Title: Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study
Abstract: Serum free light chain (FLC) concentration is greatly affected by kidney function. Using a large prospective population-based cohort, we aimed to establish a reference interval for FLCs in persons with chronic kidney disease (CKD). A total of 75422 participants of the iStopMM study were screened with serum FLC, serum protein electrophoresis and immunofixation. Estimated glomerular filtration rate (eGFR) was calculated from serum creatinine. Central 99% reference intervals were determined, and 95% confidence intervals calculated. Included were 6461 (12%) participants with measured FLCs, eGFR < 60 mL/min/1.73 m2, not receiving renal replacement therapy, and without evidence of monoclonality. Using current reference intervals, 60% and 21% had kappa and lambda FLC values outside the normal range. The FLC ratio was outside standard reference interval (0.26-1.65) in 9% of participants and outside current kidney reference interval (0.37-3.10) in 0.7%. New reference intervals for FLC and FLC ratio were established. New reference intervals for the FLC ratio were 0.46-2.62, 0.48-3.38, and 0.54-3.30 for eGFR 45-59, 30-44, and < 30 mL/min/1.73 m2 groups, respectively. The crude prevalence of LC-MGUS in CKD patients was 0.5%. We conclude that current reference intervals for FLC and FLC ratio are inaccurate in CKD patients and propose new eGFR based reference intervals to be implemented. © 2022. The Author(s).
Keywords: prospective study; prospective studies; reference values; renal insufficiency, chronic; immunoglobulin lambda chain; immunoglobulin light chain; immunoglobulin lambda-chains; immunoglobulin light chains; chronic kidney failure; reference value; humans; human
Journal Title: Blood Cancer Journal
Volume: 12
Issue: 9
ISSN: 2044-5385
Publisher: Nature Publishing Group  
Date Published: 2022-09-14
Start Page: 133
Language: English
DOI: 10.1038/s41408-022-00732-3
PUBMED: 36100605
PROVIDER: scopus
PMCID: PMC9470548
DOI/URL:
Notes: Article -- Export Date: 3 October 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors